GO-FAR评分:13个指标预测院内心跳骤停患者心肺复苏的预后

2022-02-19 MedSci原创 MedSci原创

院内心脏骤停(IHCA)仍然比较多见,而且比院外心脏骤停预后更差。尽管低温治疗心脏骤停可能改善预后,但有些经过治疗的患者预后仍然很差。为了更好地预测IHCA患者的生存预后,研究者开发了一项简单的评分&

院内心脏骤停(IHCA)仍然比较多见,而且比院外心脏骤停预后更差。尽管低温治疗心脏骤停可能改善预后,但有些经过治疗的患者预后仍然很差。为了更好地预测IHCA患者的生存预后,研究者开发了一项简单的评分——GO-FAR,共包括13个指标。

研究纳入了2007-2009年美国CPR注册中的51,240名住院患者,来自366个医院。最佳模型是一个包括13个变量的简单点评分表。13个指标为:

1.入院时神经功能损伤

2. 大的创伤

3. 急性脑卒中

4. 转移性或血液系统肿瘤

5. 脓毒症/败血症

6. 医学非心脏诊断

7. 肝功能不全

8. 由专业护理机构入院

9. 低血压或低灌注

10. 肾功能不全或透析

11. 呼吸功能不全

12. 肺炎

13. 年龄(特别是>85岁)

最近这项研究,已被反复证实,确实非常有效准确。

这个模型目前MedSci已开发成为在线版免费使用,见:院内心跳骤停患者进行心肺复苏后神经功能状态的预后预测模型(GO-FAR得分) 

原始出处:

Ebell MH, Jang W, Shen Y, Geocadin RG; Get With the Guidelines–Resuscitation Investigators.Development and validation of the Good Outcome Following Attempted Resuscitation (GO-FAR) score to predict neurologically intact survival after in-hospital cardiopulmonary resuscitation.JAMA Intern Med. 2013 Nov 11;173(20):1872-8.

Aldabagh M, Wagle S, Cesa M, Yu A, Farooq M, Goldberg Y.Survival of In-Hospital Cardiac Arrest in COVID-19 Infected Patients.Healthcare (Basel). 2021 Oct 1;9(10):1315

Cho YJ, Kim YJ, Kim MY, Shin YJ, Lee J, Choi E, Hong SB, Huh JW, Yang WS, Kim WY.Validation of the Good Outcome Following Attempted Resuscitation (GO-FAR) score in an East Asian population.
Resuscitation. 2020 May;150:36-40

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1684588, encodeId=ba41168458844, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Wed Aug 31 01:37:20 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201976, encodeId=91e712019e6b6, content=关注了13个指标, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Sat Mar 12 13:03:31 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305529, encodeId=36f2130552941, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Mon Feb 21 07:37:20 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481356, encodeId=ca371481356f5, content=<a href='/topic/show?id=60a1519e294' target=_blank style='color:#2F92EE;'>#心跳骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51972, encryptionId=60a1519e294, topicName=心跳骤停)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Feb 21 07:37:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]
    2022-08-31 aids222
  2. [GetPortalCommentsPageByObjectIdResponse(id=1684588, encodeId=ba41168458844, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Wed Aug 31 01:37:20 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201976, encodeId=91e712019e6b6, content=关注了13个指标, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Sat Mar 12 13:03:31 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305529, encodeId=36f2130552941, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Mon Feb 21 07:37:20 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481356, encodeId=ca371481356f5, content=<a href='/topic/show?id=60a1519e294' target=_blank style='color:#2F92EE;'>#心跳骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51972, encryptionId=60a1519e294, topicName=心跳骤停)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Feb 21 07:37:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]
    2022-03-12 13746658d9m

    关注了13个指标

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1684588, encodeId=ba41168458844, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Wed Aug 31 01:37:20 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201976, encodeId=91e712019e6b6, content=关注了13个指标, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Sat Mar 12 13:03:31 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305529, encodeId=36f2130552941, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Mon Feb 21 07:37:20 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481356, encodeId=ca371481356f5, content=<a href='/topic/show?id=60a1519e294' target=_blank style='color:#2F92EE;'>#心跳骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51972, encryptionId=60a1519e294, topicName=心跳骤停)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Feb 21 07:37:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]
    2022-02-21 lizhou0204
  4. [GetPortalCommentsPageByObjectIdResponse(id=1684588, encodeId=ba41168458844, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Wed Aug 31 01:37:20 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201976, encodeId=91e712019e6b6, content=关注了13个指标, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Sat Mar 12 13:03:31 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305529, encodeId=36f2130552941, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Mon Feb 21 07:37:20 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481356, encodeId=ca371481356f5, content=<a href='/topic/show?id=60a1519e294' target=_blank style='color:#2F92EE;'>#心跳骤停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51972, encryptionId=60a1519e294, topicName=心跳骤停)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Feb 21 07:37:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]

相关资讯

2019 ILCOR共识声明:心跳骤停和心肺复苏结局报告

2019年9月,国际复苏联络委员会(ILCOR)更新了心跳骤停和心肺复苏结局报告共识声明,首部用于报告心跳骤停的Utstein模式指南于1991年发布,并分别于1997年、2004年和2015年更新,本文是对院内心跳骤停Utstein模式报告指南的更新。

JAMA:血管加压素和甲强龙能显著改善院内心脏骤停患者自发循环恢复

在院内心脏骤停患者中,与安慰剂相比,给予血管加压素和甲基强的松龙能显著增加恢复自发循环的可能性。

肾结石患者行腰硬联合麻醉后心跳骤停1例

患者男,56岁,体重60kg,身高160 cm。因“左肾鹿角形结石,右输尿管上段结石,右肾积水”于2014年3月5日收入院。发现高血压1个月余,最高180/120mmHg,不规律服用降压0号、卡托普利,血压控制情况不详。无其他病史。查心电图示Ⅱ、Ⅲ、AVF导联qR波型,Ⅰ、AVL、V5、V6导联T波倒置;心脏超声检查示室间隔增厚,余指标正常。

TAVI手术中心跳骤停1例

患者男,83岁。因“活动后胸闷气短3+年,加重伴头晕10+天”于2018年12月11日入院。高血压病史3年余,平素血压150+/90+mmHg。

蛛网膜下腔阻滞后心跳骤停抢救成功1例

患者,男性,65岁,身高168 cm,体重82kg。因左侧腹股沟复发疝拟在蛛网膜下腔阻滞麻醉下行单侧腹股沟疝修补术。否认高血压、糖尿病、冠心病等病史,术前检查未见明显异常。术前未予用药。患者入室后平躺吸氧,监测生命体征心率(HR):69次/min,血氧饱和度(SpO2):98%,无创血压(NBP):137/81mmHg。

沙滩椅位肩关节镜手术可疑诱发Bezold-Jarisch反射致心跳骤停一例

患者,男,55岁,169 cm,60kg。因“外伤后右肩部疼痛、活动受限1个月,加重5d”入院。诊断为右肩袖损伤,拟在臂丛神经阻滞+全麻下行右肩关节镜检+肩袖修补术。既往史:吸烟10~20支/d;饮酒5~10次/月,200~250ml/次。青霉素过敏。无其他特殊病史,体格检查及实验室检查结果未见明显异常。